Michael J. Landine - 18 Feb 2024 Form 4 Insider Report for Alkermes plc. (ALKS)

Reporting relationship: SVP, Corp Dev., Alkermes, Inc.
Issuer ticker: ALKS
Reported as of: 18 Feb 2024
Net transaction value: +$387,239
SEC form: 4
Accepted by SEC: 21 Feb 2024, 17:37:06 UTC
Prior SEC filing: 12 Feb 2024
Next SEC filing: 23 Feb 2024
Source filing: View source filing
Reporting owner signature: /s/ Jeffrey Geary, attorney-in-fact for Michael J. Landine

Key filing fact

Michael J. Landine filed Form 4 for Alkermes plc. (ALKS) on 21 Feb 2024.

Key facts

This page summarizes Michael J. Landine's Form 4 filing for Alkermes plc. (ALKS).
20 reported transactions and 16 derivative rows are listed below.
Accepted by SEC: 21 Feb 2024, 17:37.

Change

Previous filing in this sequence was filed on 12 Feb 2024.
Current net transaction value: +$387,239.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ALKS transaction

Ordinary Shares

Options Exercise

Transaction value
Shares: +4,448
Change %: +1.7%
Price
Shares after: 273,192
Date: 18 Feb 2024
Ownership: Direct
Footnotes: F1

ALKS transaction

Ordinary Shares

Tax liability

Transaction value: $42,091
Shares: -1,308
Change %: -0.48%
Price: $32.18
Shares after: 271,884
Date: 18 Feb 2024
Ownership: Direct

ALKS transaction

Ordinary Shares

Options Exercise

Transaction value
Shares: +5,461
Change %: +2%
Price
Shares after: 277,345
Date: 20 Feb 2024
Ownership: Direct
Footnotes: F1

ALKS transaction

Ordinary Shares

Tax liability

Transaction value: $48,806
Shares: -1,606
Change %: -0.58%
Price: $30.39
Shares after: 275,739
Date: 20 Feb 2024
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ALKS transaction Derivative

Employee Stock Option (Right to Buy)

Other

Transaction value: $46,194
Shares: +999
Change %: +2%
Price: $46.24
Shares after: 50,999
Date: 17 Nov 2023
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 999
Exercise price: $46.24
Footnotes: F2, F3

ALKS transaction Derivative

Employee Stock Option (Right to Buy)

Other

Transaction value: $61,381
Shares: +879
Change %: +2%
Price: $69.83
Shares after: 44,879
Date: 17 Nov 2023
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 879
Exercise price: $69.83
Footnotes: F2, F3

ALKS transaction Derivative

Employee Stock Option (Right to Buy)

Other

Transaction value: $48,061
Shares: +1,519
Change %: +2%
Price: $31.64
Shares after: 77,519
Date: 17 Nov 2023
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 1,519
Exercise price: $31.64
Footnotes: F2, F3

ALKS transaction Derivative

Employee Stock Option (Right to Buy)

Other

Transaction value: $53,446
Shares: +999
Change %: +2%
Price: $53.50
Shares after: 50,999
Date: 17 Nov 2023
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 999
Exercise price: $53.50
Footnotes: F2, F3

ALKS transaction Derivative

Employee Stock Option (Right to Buy)

Other

Transaction value: $71,809
Shares: +1,089
Change %: +2%
Price: $65.94
Shares after: 55,589
Date: 17 Nov 2023
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 1,089
Exercise price: $65.94
Footnotes: F2, F3

ALKS transaction Derivative

Employee Stock Option (Right to Buy)

Other

Transaction value: $57,825
Shares: +1,811
Change %: +2%
Price: $31.93
Shares after: 92,411
Date: 17 Nov 2023
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 1,811
Exercise price: $31.93
Footnotes: F2, F3

ALKS transaction Derivative

Employee Stock Option (Right to Buy)

Other

Transaction value: $35,854
Shares: +1,790
Change %: +2%
Price: $20.03
Shares after: 91,335
Date: 17 Nov 2023
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 1,790
Exercise price: $20.03
Footnotes: F2, F4

ALKS transaction Derivative

Restricted Stock Unit Award

Other

Transaction value
Shares: +107
Change %: +2%
Price
Shares after: 5,461
Date: 17 Nov 2023
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 107
Exercise price
Footnotes: F1, F2, F5

ALKS transaction Derivative

Employee Stock Option (Right to Buy)

Other

Transaction value: $34,986
Shares: +1,809
Change %: +2%
Price: $19.34
Shares after: 92,296
Date: 17 Nov 2023
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 1,809
Exercise price: $19.34
Footnotes: F2, F6

ALKS transaction Derivative

Restricted Stock Unit Award

Other

Transaction value
Shares: +221
Change %: +2%
Price
Shares after: 11,309
Date: 17 Nov 2023
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 221
Exercise price
Footnotes: F1, F2, F7

ALKS transaction Derivative

Employee Stock Option (Right to Buy)

Other

Transaction value: $34,278
Shares: +1,394
Change %: +2%
Price: $24.59
Shares after: 71,171
Date: 17 Nov 2023
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 1,394
Exercise price: $24.59
Footnotes: F2, F8

ALKS transaction Derivative

Restricted Stock Unit Award

Other

Transaction value
Shares: +261
Change %: +2%
Price
Shares after: 13,345
Date: 17 Nov 2023
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 261
Exercise price
Footnotes: F1, F2, F9

ALKS transaction Derivative

Employee Stock Option (Right to Buy)

Other

Transaction value: $34,303
Shares: +1,279
Change %: +2%
Price: $26.82
Shares after: 65,241
Date: 17 Nov 2023
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 1,279
Exercise price: $26.82
Footnotes: F2, F10

ALKS transaction Derivative

Restricted Stock Unit Award

Other

Transaction value
Shares: +319
Change %: +2%
Price
Shares after: 16,310
Date: 17 Nov 2023
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 319
Exercise price
Footnotes: F1, F2, F11

ALKS transaction Derivative

Restricted Stock Unit Award

Options Exercise

Transaction value
Shares: -4,448
Change %: -33%
Price
Shares after: 8,897
Date: 18 Feb 2024
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 4,448
Exercise price
Footnotes: F1, F9

ALKS transaction Derivative

Restricted Stock Unit Award

Options Exercise

Transaction value
Shares: -5,461
Change %: -100%
Price
Shares after: 0
Date: 20 Feb 2024
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 5,461
Exercise price
Footnotes: F1, F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 11 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one ordinary share.

Footnote F2

Represents an equity award granted prior to the separation of the issuer's oncology business into Mural Oncology plc (the "Separation"), as adjusted on November 17, 2023 in connection with the Separation (in order to preserve the value associated with the original award) based on the equity adjustment terms set forth in the Employee Matters Agreement filed by the issuer as Exhibit 10.2 to its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on November 15, 2023. The exercise price (if any) of the adjusted award is shown in Boxes 2 and 8, the number of shares subject to the adjusted award is shown in Box 9 and the number of shares added to the award pursuant to the adjustment is shown in Box 5.

Footnote F3

These options are fully vested in accordance with their terms.

Footnote F4

Shares subject to the stock option award vest and become exercisable in four equal annual installments commencing on 2/20/2021.

Footnote F5

Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/20/2021.

Footnote F6

Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/22/2022.

Footnote F7

Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/22/2022.

Footnote F8

Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/18/2023.

Footnote F9

Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/18/2023.

Footnote F10

Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/23/2024.

Footnote F11

Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/23/2024.

SEC remarks

EXHIBIT LIST: Exhibit 24.1 - Power of Attorney